I’ve bought this stock because it provides a solution to an urgent health problem. Getting autism diagnosis is a costly and difficult
problem and an early screening tool with sensitivity and specificity around 85% is really good. My question is if the research is all based in the US why has it been listed on the ASX and not US based stock exchange? Is it due to Brian Leedman?
Ann: Investor Presentation, page-14
Add BB1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.030(10.0%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 26.5¢ | $40.10K | 145.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 165895 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 102157 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
27.0¢ |
Change
-0.030 ( 6.90 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 28.5¢ | 27.0¢ | 88586 | ||
| Last updated 15.44pm 07/06/2024 ? | |||||
| BB1 (ASX) Chart |